Dhingra Kapil
CIK 0001456849
Director
Filings
16
Latest Apr 7, 2026
Issuers covered
4
Showing
16 of 16
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 100% | +20.1% | +20.1% | +20.1% | +20.1% |
| 90 days | 1 | 100% | +16.2% | +16.2% | +16.2% | +16.2% |
| 180 days | - | - | - | - | - | - |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Dhingra Kapil has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| REPL | Replimune Group, Inc. | 6 | Apr 7, 2026 |
| BDTX | Black Diamond Therapeutics, Inc. | 4 | Jun 12, 2025 |
| CRGX | Cargo Therapeutics, Inc. | 4 | Aug 19, 2025 |
| LVTX | Lava Therapeutics NV | 2 | Nov 17, 2025 |
All filings
16 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|